Jim Cramer Says to Buy UnitedHealth Group Stock. Is He Right?

Source Motley_fool

Key Points

  • UnitedHealth Group's stock price has jumped almost 40% in the past two months.

  • Is Cramer right about UnitedHealth?

  • 10 stocks we like better than UnitedHealth Group ›

After falling to $255 per share in late March, UnitedHealth Group (NYSE: UNH) stock has been on a heater. The leading health insurer has skyrocketed some 57% since March 30 and is currently trading at $408 per share. It went from being down 22% year to date as of March 30 to being up 24% year to date as of June 22.

The major catalyst for the recent spike is a move by the Centers for Medicare & Medicaid Services (CMS) to raise Medicare Advantage insurers' rates by 2.48% in 2027.

Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »

And Jim Cramer, host of CNBC's Mad Money, thinks it has more room to run. He said on his show recently:

Finally, we have UnitedHealth. It's another managed care play that's up for the same reason as Humana. The stock pulled back this afternoon, but the legendary CEO, Steve Hemsley, is back, and he's so good. A brutal stint of bad management before he got there. He's turning it around. UnitedHealth, buy it.

A doctor looking at a chart with healthcare professionals in the background.

Image source: Getty Images.

Cramer also called UnitedHealth a "textbook safety stock." Is he right?

UNH is still a bargain

The Mad Money host is absolutely on the money with this call. UnitedHealth stock is still a bargain, even after its recent surge.

While its valuation has crept up, it is still trading at just 21 times forward earnings. That's because it's still down considerably from the near-$600-per-share price it hit just over a year ago in April 2025, before the tariff crash.

It may not return to $600 anytime soon, but 77% of Wall Street analysts rate it a buy, with a median price target of $420 per share.

Here are four quick reasons why UnitedHealth stock is a buy:

  1. It smashed earnings estimates last quarter.
  2. It raised its 2026 earnings guidance.
  3. It's got a high yield and a consistent dividend.
  4. As a major healthcare stock, it tends to perform well in market downturns, making it a great defensive play.

Should you buy stock in UnitedHealth Group right now?

Before you buy stock in UnitedHealth Group, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and UnitedHealth Group wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $393,037!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,280,627!*

Now, it’s worth noting Stock Advisor’s total average return is 913% — a market-crushing outperformance compared to 208% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of June 24, 2026.

Dave Kovaleski has no position in any of the stocks mentioned. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy.

Disclaimer: For information purposes only. Past performance is not indicative of future results.
placeholder
Will the Tech Rally Continue? The Technical Verdict on the NASDAQ 100 Riding a massive 32% post-earnings wave, the Nasdaq-100 is showing its first signs of exhaustion. We break down crucial exit and entry rules for long positions this week.
Author  Mitrade Team
6 Month 05 Day Fri
Riding a massive 32% post-earnings wave, the Nasdaq-100 is showing its first signs of exhaustion. We break down crucial exit and entry rules for long positions this week.
placeholder
Markets on a Wire: Imminent US Inflation Data Threatens to Lock In Fed Rate Hikes Imminent CPI and PPI data threaten to lock in a hawkish Federal Reserve rate hike cycle, leaving gold, tech equities, and Bitcoin highly vulnerable to a programmatic sell-off.
Author  Mitrade Team
6 Month 09 Day Tue
Imminent CPI and PPI data threaten to lock in a hawkish Federal Reserve rate hike cycle, leaving gold, tech equities, and Bitcoin highly vulnerable to a programmatic sell-off.
placeholder
US Attacks Iran Amid the “Ceasefire”: Bitcoin, Gold, and Oil ReactThe United States launched strikes against Iran on Tuesday after a US Apache helicopter was downed over the Strait of Hormuz, breaking the fragile ceasefire previously announced by President Donald Tr
Author  Mitrade Team
6 Month 10 Day Wed
The United States launched strikes against Iran on Tuesday after a US Apache helicopter was downed over the Strait of Hormuz, breaking the fragile ceasefire previously announced by President Donald Tr
placeholder
15 Days After SpaceX Listing, Index Funds Will Take 30% of Floating Shares, What It Means for Retail Investors?TradingKey - SpaceX (SPCX.US) is set to debut on Nasdaq on June 12, targeting a valuation of $1.75 trillion. At that time, only about 3% to 4% of total shares will be freely tradable; with founder sha
Author  Mitrade Team
6 Month 10 Day Wed
TradingKey - SpaceX (SPCX.US) is set to debut on Nasdaq on June 12, targeting a valuation of $1.75 trillion. At that time, only about 3% to 4% of total shares will be freely tradable; with founder sha
placeholder
Gold Price Analysis (XAU/USD): Gold Falls to 6-Month Low as Inflation Fuels Rate Hike Bets, A Buying Opportunity or a Falling Knife? Gold hit a 6-month low on Fed rate hike bets. However, strong central bank buying and technical indicators suggest potential tactical bounces and long-term accumulation windows.
Author  Mitrade Team
6 Month 12 Day Fri
Gold hit a 6-month low on Fed rate hike bets. However, strong central bank buying and technical indicators suggest potential tactical bounces and long-term accumulation windows.
goTop
quote